183 related articles for article (PubMed ID: 30389454)
1. Colorimetric detection of PCA3 in urine for prostate cancer diagnosis using thiol-labeled PCR primer and unmodified gold nanoparticles.
Htoo KPP; Yamkamon V; Yainoy S; Suksrichavalit T; Viseshsindh W; Eiamphungporn W
Clin Chim Acta; 2019 Jan; 488():40-49. PubMed ID: 30389454
[TBL] [Abstract][Full Text] [Related]
2. Direct colorimetric diagnosis of pathogen infections by utilizing thiol-labeled PCR primers and unmodified gold nanoparticles.
Jung YL; Jung C; Parab H; Li T; Park HG
Biosens Bioelectron; 2010 Apr; 25(8):1941-6. PubMed ID: 20138499
[TBL] [Abstract][Full Text] [Related]
3. Improved sensitivity and specificity for prostate cancer diagnosis based on the urine PCA3/PSA ratio acquired by sequence‑specific RNA capture.
Zheng K; Dou Y; He L; Li H; Zhang Z; Chen Y; Ye A; Liu W; Kong L
Oncol Rep; 2015 Nov; 34(5):2439-44. PubMed ID: 26351770
[TBL] [Abstract][Full Text] [Related]
4. Expression of PCA3 and PSA genes as a biomarker for differential diagnosis of nodular hyperplasia and prostate cancer.
Coelho FF; Guimarães FL; Cabral WL; Salles PG; Mateo EC; Nogueira e Nogueira LM; Fonseca CE; Gomes KB
Genet Mol Res; 2015 Oct; 14(4):13519-31. PubMed ID: 26535666
[TBL] [Abstract][Full Text] [Related]
5. Differential display code 3 (DD3/PCA3) in prostate cancer diagnosis.
Klecka J; Holubec L; Pesta M; Topolcan O; Hora M; Eret V; Finek J; Chottova-Dvorakova M; Babjuk M; Novak K; Stolz J
Anticancer Res; 2010 Feb; 30(2):665-70. PubMed ID: 20332487
[TBL] [Abstract][Full Text] [Related]
6. PSGR and PCA3 as biomarkers for the detection of prostate cancer in urine.
Rigau M; Morote J; Mir MC; Ballesteros C; Ortega I; Sanchez A; Colás E; Garcia M; Ruiz A; Abal M; Planas J; Reventós J; Doll A
Prostate; 2010 Dec; 70(16):1760-7. PubMed ID: 20672322
[TBL] [Abstract][Full Text] [Related]
7. Real-time colorimetric detection of DNA methylation of the
Huang J; Liou YL; Kang YN; Tan ZR; Peng MJ; Zhou HH
Int J Nanomedicine; 2016; 11():5335-5347. PubMed ID: 27789946
[TBL] [Abstract][Full Text] [Related]
8. Urinary
Yamkamon V; Htoo KPP; Yainoy S; Suksrichavalit T; Tangchaikeeree T; Eiamphungporn W
EXCLI J; 2020; 19():501-513. PubMed ID: 32398974
[No Abstract] [Full Text] [Related]
9. "Mix-to-Go" Silver Colloidal Strategy for Prostate Cancer Molecular Profiling and Risk Prediction.
Wang J; Koo KM; Wang Y; Trau M
Anal Chem; 2018 Nov; 90(21):12698-12705. PubMed ID: 30260630
[TBL] [Abstract][Full Text] [Related]
10. Real-time PCR PCA3 assay is a useful test measured in urine to improve prostate cancer detection.
Foj L; Milà M; Mengual L; Luque P; Alcaraz A; Jiménez W; Filella X
Clin Chim Acta; 2014 Aug; 435():53-8. PubMed ID: 24803095
[TBL] [Abstract][Full Text] [Related]
11. Unmodified gold nanoparticles as a simple colorimetric probe for ramoplanin detection.
Teepoo S; Chumsaeng P; Palasak K; Bousod N; Mhadbamrung N; Sae-lim P
Talanta; 2013 Dec; 117():518-22. PubMed ID: 24209375
[TBL] [Abstract][Full Text] [Related]
12. Prostate cancer antigen 3 (PCA3) RNA detection in blood and tissue samples for prostate cancer diagnosis.
Neves AF; Dias-Oliveira JD; Araújo TG; Marangoni K; Goulart LR
Clin Chem Lab Med; 2013 Apr; 51(4):881-7. PubMed ID: 23241599
[TBL] [Abstract][Full Text] [Related]
13. Progensa™ PCA3 test for prostate cancer.
Durand X; Moutereau S; Xylinas E; de la Taille A
Expert Rev Mol Diagn; 2011 Mar; 11(2):137-44. PubMed ID: 21405964
[TBL] [Abstract][Full Text] [Related]
14. Quantitative real-time RT-PCR assay for PCA3.
Väänänen RM; Rissanen M; Kauko O; Junnila S; Väisänen V; Nurmi J; Alanen K; Nurmi M; Pettersson K
Clin Biochem; 2008 Jan; 41(1-2):103-8. PubMed ID: 17996198
[TBL] [Abstract][Full Text] [Related]
15. Molecular PCA3 diagnostics on prostatic fluid.
van Gils MP; Cornel EB; Hessels D; Peelen WP; Witjes JA; Mulders PF; Rittenhouse HG; Schalken JA
Prostate; 2007 Jun; 67(8):881-7. PubMed ID: 17440939
[TBL] [Abstract][Full Text] [Related]
16. Development of extremely stable dual functionalized gold nanoparticles for effective colorimetric detection of clenbuterol and ractopamine in human urine samples.
Simon T; Shellaiah M; Steffi P; Sun KW; Ko FH
Anal Chim Acta; 2018 Sep; 1023():96-104. PubMed ID: 29754612
[TBL] [Abstract][Full Text] [Related]
17. Colorimetric theophylline aggregation assay using an RNA aptamer and non-crosslinking gold nanoparticles.
Ma X; Guo Z; Mao Z; Tang Y; Miao P
Mikrochim Acta; 2017 Dec; 185(1):33. PubMed ID: 29594625
[TBL] [Abstract][Full Text] [Related]
18. Colorimetric detection of low dose gamma radiation based on the aggregation of gold nanoparticles and its application for the blood irradiation.
Song Y; Feng D; Shao S; Liang J
Talanta; 2018 Sep; 187():308-313. PubMed ID: 29853052
[TBL] [Abstract][Full Text] [Related]
19. Nanodiamonds conjugated to gold nanoparticles for colorimetric detection of clenbuterol and chromium(III) in urine.
Shellaiah M; Simon T; Venkatesan P; Sun KW; Ko FH; Wu SP
Mikrochim Acta; 2017 Dec; 185(1):74. PubMed ID: 29594526
[TBL] [Abstract][Full Text] [Related]
20. Prostate cancer antigen 3 gene expression in peripheral blood and urine sediments from prostate cancer and benign prostatic hyperplasia patients versus healthy individuals.
Moradi Sardareh H; Goodarzi MT; Yadegar-Azari R; Poorolajal J; Mousavi-Bahar SH; Saidijam M
Urol J; 2014 Nov; 11(6):1952-8. PubMed ID: 25433473
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]